Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
TAICANG , JIANGSU, CHINA, December 31, 2025 /EINPresswire.com/ — Climate neutrality and energy efficiency initiatives continue to shape industries across the board, with built environments being one ...
That’s the aim of predictive cyber resilience (PCR)—an emerging approach to security built on intelligence, automation and ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...
In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping ...
Among recycled materials, polyethylene terephthalate (PET) holds the largest share of the U.S. PCR films market, accounting ...
Global leader in memory modules and flash storage, ADATA Technology Co., Ltd. will present its latest breakthroughs at CES ...
Chemist Anne Lüscher showed at 39C3 how synthetic DNA can be used for data storage and tamper-proof authentication.
In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...
Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback